Is micro-CT effective for assessing tumour margins during breast-conserving surgery?

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-04-19 04:00 GMT   |   Update On 2023-04-19 10:41 GMT
Advertisement

USA: A recent study published in Annals of Surgical Oncology revealed that micro-CT (computed tomography) is promising as an additional tool to standard-of-care evaluation of tumour margins during breast-conserving surgery.

The researchers wrote, "Micro-CT identified the same proportion of margin-positive cases as standard specimen radiography and palpation, but due to difficulty differentiating between cancer and radiodense fibro glandular tissue, resulted in a higher proportion of false positive margin assessments."

Advertisement

Breast-conserving surgery (BCS) is an essential early-stage breast cancer treatment component. However, costly re-excision procedures are frequent due to the high prevalence of cancer-positive margins on primary resections. Standard-of-care assessment of breast tumour specimens comprises visual examination and radiography plus palpation. Still, this approach can be limited by overlapping radiodensities of tumour and breast tissues that tend to obscure lesion borders. Therefore, there is a need to develop and evaluate improved methods of margin assessment for the intraoperative detection of positive margins.

"The success of breast-conserving surgery is based on the ability of the surgical team to evaluate resection margins thoroughly and rapidly during the initial procedure to avoid costly re-excision procedures associated with worse cosmetic outcomes, increased patient distress, and increased medical costs," the team wrote.

For this purpose, Samuel S. Streeter, Dartmouth College, Hanover, NH, USA, and colleagues conducted a prospective trial through which micro-CT with radiological interpretation was evaluated by three independent readers for BCS margin assessment. Findings were compared to standard-of-care intraoperative margin assessment (i.e., SIA (specimen palpation and radiography) for cancer-positive margins detection.

The authors reported the following findings:

  • Six hundred margins were analyzed from 100 patients. Twenty-one margins in 14 patients were pathologically positive.
  • On analysis at the specimen level, SIA yielded a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 42.9%, 76.7%, 23.1%, and 89.2%, respectively.
  • SIA correctly identified six of 14 margin-positive cases with a 23.5% false positive rate (FPR).
  • Micro-CT readers achieved sensitivity, specificity, PPV, and NPV ranges of 35.7–50.0%, 55.8–68.6%, 15.6–15.8%, and 86.8–87.3%, respectively.
  • Micro-CT readers correctly identified five to seven of 14 margin-positive cases with an FPR range of 31.4–44.2%.
  • If micro-CT scanning had been combined with SIA, up to three additional margin-positive specimens would have been identified.

"There is a need for additional studies to capture better the effectiveness of micro-CT scanning for intraoperative margin assessment burning BCS," the authors conclude. "The focus o these studies should be reporting institutional standard-of-care techniques for intraoperative margin assessment, along with details related to duration allowed for image interpretation, how and when radiological interpretation is performed, and the quality of micro-CT scanning to understand better and characterize the differences between published breast-conserving surgery specimen datasets and reported margin assessment performances."

Reference:

Streeter, S.S., Zuurbier, R.A., diFlorio-Alexander, R.M. et al. Breast-Conserving Surgery Margin Guidance Using Micro-Computed Tomography: Challenges When Imaging Radiodense Resection Specimens. Ann Surg Oncol (2023). https://doi.org/10.1245/s10434-023-13364-z

Tags:    
Article Source : Annals of Surgical Oncology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News